Longevity New trial data supports Alzheimer’s drug candidate’s ‘disease-modifying’ potentialBy adminOctober 12, 20250 Annovis Bio’s buntanetap found to reduce inflammation biomarkers and improve cellular health in Alzheimer’s patients. Neurodegeneration-focused biotech Annovis Bio has…
